ONBREZ BREEZHALER 300mcg capsules with inhalation powder medication leaflet

R03AC18 indacaterol • Respiratory system | Adrenergics, inhalants | Selective beta-2-adrenoreceptor agonists

Indacaterol is a bronchodilator used to treat chronic obstructive pulmonary disease (COPD). It belongs to the class of long-acting beta-2 adrenergic agonists and helps relax the muscles of the airways, making breathing easier.

The medication is administered via inhalation, usually once daily, as directed by a doctor.

Side effects may include cough, headache, dizziness, or throat irritation. In rare cases, severe allergic reactions or palpitations may occur.

Patients should strictly follow the usage instructions and inform their doctor about any other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about ONBREZ BREEZHALER 300mcg

Substance: indacaterol

Date of last drug list: 01-05-2026

Commercial code: W64464002

Concentration: 300mcg

Pharmaceutical form: capsules with inhalation powder

Quantity: 30

Product type: original

Price: 137.30 RON

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: NOVARTIS PHARMA GMBH - GERMANIA

Holder: NOVARTIS EUROPHARM LIMITED - IRLANDA

Number: 593/2009/07

Shelf life: 30 months

Concentrations available for indacaterol

150mcg, 300mcg
PDF icon EMA leaflet
Published: 05/01/2010
Updated: 18/11/2025

Compensation lists for ONBREZ BREEZHALER 300mcg Europharm

B - Sublist B with 50% discount from the reference price

Price

Copayment

Patient

137.30 RON

68.65 RON

68.65 RON